Top compounds associated with response to CLCC1


Feature Type Standardized
Nominal ANOVA
mRNA BMS-195614 CTRPv2 pan-cancer AAC -0.027 0.5
mRNA lapatinib UHNBreast pan-cancer AAC 0.2 0.5
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.021 0.5
mRNA temsirolimus CTRPv2 pan-cancer AAC 0.033 0.5
mRNA SID 26681509 CTRPv2 pan-cancer AAC 0.026 0.5
mRNA salermide CTRPv2 pan-cancer AAC 0.032 0.5
mRNA BRD-K33199242 CTRPv2 pan-cancer AAC 0.025 0.5
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.024 0.5
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.024 0.5
mRNA PRIMA-1-Met CTRPv2 pan-cancer AAC -0.035 0.5
Download CSV